Mukherjee Mana Mohan, Xu Peng, Stevens Edwin D, Kováč Pavol
LBC, NIDDK, National Institutes of Health, Bethesda, MD 20892-0815.
Department of Chemistry, Western Kentucky University, Bowling Green, KY, 42101.
RSC Adv. 2019;9(62):36440-36454. doi: 10.1039/c9ra08232h. Epub 2019 Nov 8.
Synthesis of the upstream terminal hexasaccharide part of the lipopolysaccharides (LPS) of O1, serotype Inaba has been improved. The key improvements include but are not limited to optimized conditions for the stereoselectivity of glycosylation reactions involved and fewer number of synthetic steps, compared to previous approaches. Particularly noteworthy is conducting the glycosylation of the very reactive glycosyl acceptor 8-azido-3,6-dioxaoctanol with the fully assembled hexasaccharide trichloroacetimidate under thermodynamic control. It produced the desired α glycoside with an α:β ratio of 7:1, compared with the ratio of 1.1:1, observed when the coupling was conducted conventionally. Several substances, which were previously obtained in purity acceptable only for synthetic intermediates, were now obtained in the analytically pure state and were fully characterized. The structure of the key trisaccharide glycosyl acceptor was confirmed by single-crystal x-ray structure determination.
O1群稻叶型血清型脂多糖(LPS)上游末端六糖部分的合成方法得到了改进。关键改进包括但不限于:与之前的方法相比,参与糖基化反应的立体选择性条件得到优化,合成步骤数量减少。特别值得注意的是,在热力学控制下,使极具反应活性的糖基受体8-叠氮基-3,6-二氧杂辛醇与完全组装好的六糖三氯乙酰亚胺酯进行糖基化反应。与传统偶联反应时观察到的1.1:1的α:β比例相比,该反应生成了α:β比例为7:1的所需α糖苷。几种之前仅作为合成中间体时纯度可接受的物质,现在已获得分析纯状态,并进行了全面表征。关键三糖糖基受体的结构通过单晶X射线结构测定得以确认。